Kuei Hsien Chen

1 Introduction Subcellular targeting, particularly mitochondrial targeting, is a powerful strategy in precision cancer therapy because it allows for highly specific intervention at the organelle level. Mitochondria are not only the powerhouse of the cell but also key regulators of apoptosis, metabolic signaling, and redox homeostasis—processes [1]. Given their central role in orchestrating programmed cell death, mitochondria represent an attractive target for precise therapeutic interventions.

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.